Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity

Post time 3 day(s) ago

journal：European Journal of Medicinal Chemistry

Authors：Saghar Mozaffari; David Salehi; Parvin Mahdipoor; Richard Beuttler; Rakesh Tiwari; Hamidreza Montazeri Aliabadi; Keykavous Parang

Published date：2021-12-

DOI：10.1016/j.ejmech.2021.113836

PDF link：https://www.sciencedirect.com/sc ... 223523421006851/pdf

Article link：http://dx.doi.org/10.1016/j.ejmech.2021.113836

Article Source：Elsevier BV。

Remark：

Post time 3 day(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Elsevier] Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity Copy

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity